{"transactions":[{"id":4626181,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":1222,"price":82.2768,"value":100542.2496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $82.08 to $82.56, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23792,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":4626180,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":2270,"price":81.6699,"value":185390.673,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $81.08 to $82.0791, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":25014,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":4626179,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":1325,"price":80.8164,"value":107081.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $80.08 to $81.0769, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":27284,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":4626178,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":614,"price":79.5114,"value":48819.9996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $79.075 to $80.07, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":28609,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":4626177,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:30:50.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":292,"price":78.1959,"value":22833.2028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.76 to $78.74, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":29223,"source":{"system":"sec-edgar","filing":"0001610717-26-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/form4.xml","form_type":"4"}},{"id":4626163,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":2800,"price":82.365,"value":230622.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $82.28 to $82.53, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1050249,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":4626162,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":9900,"price":81.8254,"value":810071.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $81.28 to $82.25 inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1053049,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":4626161,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":9300,"price":80.9033,"value":752400.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $80.28 to $81.27, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1062949,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":4626160,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":79.6195,"value":159239.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $79.11 to $80.07, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1072249,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":4626159,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-24T20:29:44.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":78.2284,"value":78228.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.75 to $78.73, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1074249,"source":{"system":"sec-edgar","filing":"0001610717-26-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000421/form4.xml","form_type":"4"}},{"id":4616029,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:47:39.000Z","date":"2026-09-09","kind":"sale","planned":true,"acquired":false,"shares":13754,"price":65.2574,"value":897550.2796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $64.88 to $65.875, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":316344,"source":{"system":"sec-edgar","filing":"0001610717-26-000414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1971187/000161071726000414/form4.xml","form_type":"4"}},{"id":4616028,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:47:39.000Z","date":"2026-09-09","kind":"sale","planned":true,"acquired":false,"shares":31428,"price":64.3097,"value":2021125.2516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $64.01 to $64.87, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":330098,"source":{"system":"sec-edgar","filing":"0001610717-26-000414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971187/000161071726000414/form4.xml","form_type":"4"}},{"id":4616027,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:47:39.000Z","date":"2026-09-09","kind":"sale","planned":true,"acquired":false,"shares":1206,"price":63.6774,"value":76794.9444,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $63.67 to $63.83, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":361526,"source":{"system":"sec-edgar","filing":"0001610717-26-000414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971187/000161071726000414/form4.xml","form_type":"4"}},{"id":3630389,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-08T23:00:27.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":6174,"price":62.6066,"value":386533.1484,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $62.50 to $62.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":328436,"source":{"system":"sec-edgar","filing":"0001610717-26-000405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000405/form4.xml","form_type":"4"}},{"id":3630388,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-08T23:00:27.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":6814,"price":62.1082,"value":423205.2748,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $61.435 to $62.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":334610,"source":{"system":"sec-edgar","filing":"0001610717-26-000405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000405/form4.xml","form_type":"4"}},{"id":3630387,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-08T23:00:27.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":7012,"price":60.6579,"value":425333.1948,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $60.435 to $61.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":341424,"source":{"system":"sec-edgar","filing":"0001610717-26-000405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000405/form4.xml","form_type":"4"}},{"id":3135,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-03T21:19:42.000Z","date":"2026-09-01","kind":"gift","planned":false,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1075249,"source":{"system":"sec-edgar","filing":"0001610717-26-000396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786720/000161071726000396/form4.xml","form_type":"4"}},{"id":672713,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-28T19:22:30.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":492,"price":64.7465,"value":31855.278,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $64.59 to $64.99, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1075349,"source":{"system":"sec-edgar","filing":"0001610717-26-000393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000393/form4.xml","form_type":"4"}},{"id":672712,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-28T19:22:30.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":6494,"price":63.9768,"value":415465.3392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $63.56 to $64.54, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1075841,"source":{"system":"sec-edgar","filing":"0001610717-26-000393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000393/form4.xml","form_type":"4"}},{"id":672711,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-28T19:22:30.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":63.0229,"value":220580.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $62.53 to $63.50, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1082335,"source":{"system":"sec-edgar","filing":"0001610717-26-000393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000393/form4.xml","form_type":"4"}},{"id":674562,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-26T20:46:04.000Z","date":"2026-08-24","kind":"sale","planned":false,"acquired":false,"shares":18545,"price":63.0237,"value":1168774.5165,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.78, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1085835,"source":{"system":"sec-edgar","filing":"0001610717-26-000392","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000392/form4.xml","form_type":"4"}},{"id":674561,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-26T20:44:46.000Z","date":"2026-08-24","kind":"sale","planned":false,"acquired":false,"shares":17166,"price":63.023,"value":1081852.818,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.73, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":362732,"source":{"system":"sec-edgar","filing":"0001610717-26-000391","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000391/form4.xml","form_type":"4"}},{"id":674558,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2026-08-26T20:43:52.000Z","date":"2026-08-24","kind":"sale","planned":false,"acquired":false,"shares":13818,"price":63.0236,"value":870860.1048,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.78, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":488182,"source":{"system":"sec-edgar","filing":"0001610717-26-000390","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000390/form4.xml","form_type":"4"}},{"id":674608,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-26T20:42:00.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":1646,"price":63.9664,"value":105288.6944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $63.42 to $64.29, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":29515,"source":{"system":"sec-edgar","filing":"0001610717-26-000389","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000389/form4.xml","form_type":"4"}},{"id":674607,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-26T20:42:00.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":561,"price":62.7259,"value":35189.2299,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $62.26 to $63.23, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":31161,"source":{"system":"sec-edgar","filing":"0001610717-26-000389","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000389/form4.xml","form_type":"4"}},{"id":677062,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-24T20:16:39.000Z","date":"2026-08-20","kind":"gift","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1104380,"source":{"system":"sec-edgar","filing":"0001610717-26-000386","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000386/form4.xml","form_type":"4"}},{"id":685808,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":22969,"kind":"person","name":"Teichmann Sarah A.","position":1,"cik":"0002030916","reported_name":"Teichmann Sarah A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-17T20:08:49.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":2273,"price":57.15,"value":129901.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 14, 2026."}],"balance_after":28058,"source":{"system":"sec-edgar","filing":"0001610717-26-000359","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2030916/000161071726000359/form4.xml","form_type":"4"}},{"id":685807,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":22969,"kind":"person","name":"Teichmann Sarah A.","position":1,"cik":"0002030916","reported_name":"Teichmann Sarah A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-17T20:08:49.000Z","date":"2026-08-13","kind":"sale","planned":true,"acquired":false,"shares":5278,"price":57.29,"value":302376.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 14, 2026."}],"balance_after":30331,"source":{"system":"sec-edgar","filing":"0001610717-26-000359","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030916/000161071726000359/form4.xml","form_type":"4"}},{"id":687814,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-13T16:11:23.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":58.725,"value":176175.0,"ownership":{"direct":true},"balance_after":348436,"source":{"system":"sec-edgar","filing":"0001610717-26-000358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071726000358/form4.xml","form_type":"4"}},{"id":687813,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-13T16:11:23.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":17000,"price":57.5812,"value":978880.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $57.50 to $58.1525. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":351436,"source":{"system":"sec-edgar","filing":"0001610717-26-000358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071726000358/form4.xml","form_type":"4"}},{"id":727255,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T20:22:49.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":1661,"price":36.1646,"value":60069.4006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $35.98 to $36.24, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1108380,"source":{"system":"sec-edgar","filing":"0001610717-26-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000293/form4.xml","form_type":"4"}},{"id":727254,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T20:22:49.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":9821,"price":35.3159,"value":346837.4539,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $34.86 to $35.82, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1110041,"source":{"system":"sec-edgar","filing":"0001610717-26-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000293/form4.xml","form_type":"4"}},{"id":727253,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T20:22:49.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":9991,"price":34.2815,"value":342506.4665,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $33.76 to $34.71, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1119862,"source":{"system":"sec-edgar","filing":"0001610717-26-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000293/form4.xml","form_type":"4"}},{"id":727252,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T20:22:49.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":8527,"price":33.289,"value":283855.303,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.75 to $33.74, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1129853,"source":{"system":"sec-edgar","filing":"0001610717-26-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000293/form4.xml","form_type":"4"}},{"id":731628,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:08:03.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":364,"price":33.2738,"value":12111.6632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $33.03 to $33.49, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":31722,"source":{"system":"sec-edgar","filing":"0001610717-26-000242","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000242/form4.xml","form_type":"4"}},{"id":731627,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:08:03.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":5359,"price":32.589,"value":174644.451,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.03 to $33.02, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":32086,"source":{"system":"sec-edgar","filing":"0001610717-26-000242","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000242/form4.xml","form_type":"4"}},{"id":746536,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":22969,"kind":"person","name":"Teichmann Sarah A.","position":1,"cik":"0002030916","reported_name":"Teichmann Sarah A.","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-08T23:27:27.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":35609,"source":{"system":"sec-edgar","filing":"0001610717-26-000196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030916/000161071726000196/form4.xml","form_type":"4"}},{"id":745755,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-08T23:26:38.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":37445,"source":{"system":"sec-edgar","filing":"0001610717-26-000195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071726000195/form4.xml","form_type":"4"}},{"id":745897,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-08T23:25:23.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":37445,"source":{"system":"sec-edgar","filing":"0001610717-26-000193","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000161071726000193/form4.xml","form_type":"4"}},{"id":745786,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":40384,"kind":"person","name":"MATEO ALAN","position":1,"cik":"0001595244","reported_name":"MATEO ALAN","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-08T23:24:34.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":85877,"source":{"system":"sec-edgar","filing":"0001610717-26-000192","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595244/000161071726000192/form4.xml","form_type":"4"}},{"id":745760,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":40369,"kind":"person","name":"Kosaraju Sridhar","position":1,"cik":"0001651325","reported_name":"Kosaraju Sridhar","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-08T23:23:39.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":65278,"source":{"system":"sec-edgar","filing":"0001610717-26-000191","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651325/000161071726000191/form4.xml","form_type":"4"}},{"id":745964,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-08T19:26:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":368436,"source":{"system":"sec-edgar","filing":"0001610717-26-000194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071726000194/form4.xml","form_type":"4"}},{"id":761188,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-27T21:57:37.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":10718,"price":24.7092,"value":264833.2056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $24.45 to $24.88, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1138380,"source":{"system":"sec-edgar","filing":"0001610717-26-000164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000164/form4.xml","form_type":"4"}},{"id":761187,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-27T21:57:37.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":18175,"price":24.4415,"value":444224.2625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1149098,"source":{"system":"sec-edgar","filing":"0001610717-26-000164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000164/form4.xml","form_type":"4"}},{"id":761186,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2026-05-27T21:56:46.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":11595,"price":24.4415,"value":283399.1925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":502000,"source":{"system":"sec-edgar","filing":"0001610717-26-000163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000163/form4.xml","form_type":"4"}},{"id":761185,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-27T21:55:41.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":15098,"price":24.4415,"value":369017.767,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":379898,"source":{"system":"sec-edgar","filing":"0001610717-26-000162","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000162/form4.xml","form_type":"4"}},{"id":806792,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-16T20:07:33.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":24.5568,"value":122784.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $24.49 to $24.70, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1167273,"source":{"system":"sec-edgar","filing":"0001610717-26-000145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000145/form4.xml","form_type":"4"}},{"id":827950,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-25T21:15:13.000Z","date":"2026-03-24","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":19.5223,"value":97611.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $19.49 to $19.59, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1172273,"source":{"system":"sec-edgar","filing":"0001610717-26-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000134/form4.xml","form_type":"4"}},{"id":827949,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-25T21:15:13.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":19.1297,"value":191297.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.78 to $19.41, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the transfer by the Reporting Person of 13,644 shares of Class A Common Stock to the Y/S Pot Trust on March 3, 2026."}],"balance_after":1177273,"source":{"system":"sec-edgar","filing":"0001610717-26-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000134/form4.xml","form_type":"4"}},{"id":860518,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T21:14:12.000Z","date":"2026-03-03","kind":"gift","planned":true,"acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1200917,"source":{"system":"sec-edgar","filing":"0001610717-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000086/form4.xml","form_type":"4"}},{"id":860517,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T21:14:12.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":1860,"price":23.1781,"value":43111.266,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $23.15 to $23.25, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1203667,"source":{"system":"sec-edgar","filing":"0001610717-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000086/form4.xml","form_type":"4"}},{"id":860516,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T21:14:12.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":14292,"price":22.669,"value":323985.348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.15 to $23.145, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1205527,"source":{"system":"sec-edgar","filing":"0001610717-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000086/form4.xml","form_type":"4"}},{"id":873352,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-02T21:24:35.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":157895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1219819,"source":{"system":"sec-edgar","filing":"0001610717-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000077/form4.xml","form_type":"4"}},{"id":873353,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2026-03-02T21:23:49.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":88816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":513595,"source":{"system":"sec-edgar","filing":"0001610717-26-000076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000076/form4.xml","form_type":"4"}},{"id":873351,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-02T21:23:09.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":106579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":394996,"source":{"system":"sec-edgar","filing":"0001610717-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000075/form4.xml","form_type":"4"}},{"id":877675,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":22969,"kind":"person","name":"Teichmann Sarah A.","position":1,"cik":"0002030916","reported_name":"Teichmann Sarah A.","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-02-27T21:01:20.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":7579,"price":19.41,"value":147108.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 26, 2025."}],"balance_after":26780,"source":{"system":"sec-edgar","filing":"0001610717-26-000074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030916/000161071726000074/form4.xml","form_type":"4"}},{"id":881333,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:52:57.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":9632,"price":18.5764,"value":178927.8848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1061924,"source":{"system":"sec-edgar","filing":"0001610717-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000070/form4.xml","form_type":"4"}},{"id":881332,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:51:56.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":8968,"price":18.5764,"value":166593.1552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":288417,"source":{"system":"sec-edgar","filing":"0001610717-26-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000069/form4.xml","form_type":"4"}},{"id":881331,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:51:01.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":7826,"price":18.5764,"value":145378.9064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":424779,"source":{"system":"sec-edgar","filing":"0001610717-26-000068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000068/form4.xml","form_type":"4"}},{"id":943896,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T21:52:55.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":32537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":173600,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":32537},"source":{"system":"sec-edgar","filing":"0001610717-26-000003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000003/form4.xml","form_type":"4"}},{"id":943895,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T21:52:55.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":17463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares subject to the option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":17463},"source":{"system":"sec-edgar","filing":"0001610717-26-000003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000003/form4.xml","form_type":"4"}},{"id":943894,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-01-07T21:52:55.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":1.2,"value":60000.0,"ownership":{"direct":true},"balance_after":1071556,"source":{"system":"sec-edgar","filing":"0001610717-26-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000003/form4.xml","form_type":"4"}},{"id":988317,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-25T22:24:48.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":11888,"price":18.9983,"value":225851.7904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":297385,"source":{"system":"sec-edgar","filing":"0001610717-25-000400","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000400/form4.xml","form_type":"4"}},{"id":988316,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2025-11-25T22:24:04.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":8283,"price":18.9983,"value":157362.9189,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":432605,"source":{"system":"sec-edgar","filing":"0001610717-25-000399","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000399/form4.xml","form_type":"4"}},{"id":988315,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-25T22:23:35.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":13261,"price":18.9983,"value":251936.4563,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1021556,"source":{"system":"sec-edgar","filing":"0001610717-25-000398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000398/form4.xml","form_type":"4"}},{"id":1038980,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-16T20:37:26.000Z","date":"2025-09-12","kind":"gift","planned":false,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1034817,"source":{"system":"sec-edgar","filing":"0001610717-25-000341","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000341/form4.xml","form_type":"4"}},{"id":1055283,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-26T20:15:30.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":9348,"price":13.787,"value":128880.876,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":945892,"source":{"system":"sec-edgar","filing":"0001610717-25-000321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000321/form4.xml","form_type":"4"}},{"id":1055284,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-26T20:14:27.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":22315,"price":13.787,"value":307656.905,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":309273,"source":{"system":"sec-edgar","filing":"0001610717-25-000320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000320/form4.xml","form_type":"4"}},{"id":1055282,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2025-08-26T20:12:55.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":7486,"price":13.787,"value":103209.482,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":440888,"source":{"system":"sec-edgar","filing":"0001610717-25-000319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000319/form4.xml","form_type":"4"}},{"id":1114528,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-11T22:31:49.000Z","date":"2025-06-09","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects transfer of 88,955 shares to Sirius Trust and 35,430 shares to Y/S Pot Trust on June 5, 2025."}],"balance_after":955240,"source":{"system":"sec-edgar","filing":"0001610717-25-000199","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000199/form4.xml","form_type":"4"}},{"id":1121665,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":22969,"kind":"person","name":"Teichmann Sarah A.","position":1,"cik":"0002030916","reported_name":"Teichmann Sarah A.","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-05T21:25:01.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":15357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":34359,"source":{"system":"sec-edgar","filing":"0001610717-25-000172","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030916/000161071725000172/form4.xml","form_type":"4"}},{"id":1120871,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19373,"kind":"person","name":"SULIMAN SHEHNAAZ","position":1,"cik":"0001713070","reported_name":"SULIMAN SHEHNAAZ","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-05T21:22:49.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":15357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":28616,"source":{"system":"sec-edgar","filing":"0001610717-25-000171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713070/000161071725000171/form4.xml","form_type":"4"}},{"id":1121008,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-05T21:21:37.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":15357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":28616,"source":{"system":"sec-edgar","filing":"0001610717-25-000169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000161071725000169/form4.xml","form_type":"4"}},{"id":1120897,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":40384,"kind":"person","name":"MATEO ALAN","position":1,"cik":"0001595244","reported_name":"MATEO ALAN","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-05T21:20:49.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":15357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":77048,"source":{"system":"sec-edgar","filing":"0001610717-25-000168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595244/000161071725000168/form4.xml","form_type":"4"}},{"id":1120879,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":40369,"kind":"person","name":"Kosaraju Sridhar","position":1,"cik":"0001651325","reported_name":"Kosaraju Sridhar","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-05T21:19:41.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":15357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":56449,"source":{"system":"sec-edgar","filing":"0001610717-25-000167","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651325/000161071725000167/form4.xml","form_type":"4"}},{"id":1121072,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-05T17:22:22.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":15357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":359607,"source":{"system":"sec-edgar","filing":"0001610717-25-000170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071725000170/form4.xml","form_type":"4"}},{"id":1127161,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-02T21:16:35.000Z","date":"2025-05-29","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1080625,"source":{"system":"sec-edgar","filing":"0001610717-25-000147","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000147/form4.xml","form_type":"4"}},{"id":1132876,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-27T21:08:05.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":9343,"price":8.2993,"value":77540.3599,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1083625,"source":{"system":"sec-edgar","filing":"0001610717-25-000144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000144/form4.xml","form_type":"4"}},{"id":1132877,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2025-05-27T21:07:25.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":7485,"price":8.2993,"value":62120.2605,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":448374,"source":{"system":"sec-edgar","filing":"0001610717-25-000143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000143/form4.xml","form_type":"4"}},{"id":1132875,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-27T21:06:35.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":4044,"price":8.2993,"value":33562.3692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":331588,"source":{"system":"sec-edgar","filing":"0001610717-25-000142","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000142/form4.xml","form_type":"4"}},{"id":1196656,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-19T21:35:44.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":171428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1092968,"source":{"system":"sec-edgar","filing":"0001610717-25-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000075/form4.xml","form_type":"4"}},{"id":1196655,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2025-03-19T21:35:12.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":120535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":455859,"source":{"system":"sec-edgar","filing":"0001610717-25-000074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000074/form4.xml","form_type":"4"}},{"id":1196654,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-19T21:34:38.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":133928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Constitute RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":335632,"source":{"system":"sec-edgar","filing":"0001610717-25-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000073/form4.xml","form_type":"4"}},{"id":1196653,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19366,"kind":"person","name":"Taich Adam","position":1,"cik":"0001971187","reported_name":"Taich Adam","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-19T21:34:38.000Z","date":"2024-10-23","kind":"grant","planned":false,"acquired":true,"shares":201704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on August 21, 2024 and 1/16th of the RSUs shall vest on each quarterly anniversary thereafter for the following three years, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":201704,"source":{"system":"sec-edgar","filing":"0001610717-25-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000073/form4.xml","form_type":"4"}},{"id":1225900,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T23:50:19.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, originally for 300,000 shares, of which 282,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021."}],"balance_after":17463,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001610717-25-000049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000049/form4.xml","form_type":"4"}},{"id":1225899,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:50:19.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":1.2,"value":60000.0,"ownership":{"direct":true},"balance_after":921540,"source":{"system":"sec-edgar","filing":"0001610717-25-000049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000049/form4.xml","form_type":"4"}},{"id":1225898,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:50:19.000Z","date":"2025-02-28","kind":"sale","planned":true,"acquired":false,"shares":7942,"price":10.6262,"value":84393.2804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on September 12, 2024 and terminated effective March 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.415 to $10.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":871540,"source":{"system":"sec-edgar","filing":"0001610717-25-000049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000049/form4.xml","form_type":"4"}},{"id":1242346,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2025-02-26T22:43:37.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":4573,"price":11.0656,"value":50602.9888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":335324,"source":{"system":"sec-edgar","filing":"0001610717-25-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000037/form4.xml","form_type":"4"}},{"id":1242344,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-26T22:42:46.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":5092,"price":11.0656,"value":56346.0352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":879482,"source":{"system":"sec-edgar","filing":"0001610717-25-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071725000036/form4.xml","form_type":"4"}},{"id":1245240,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":40384,"kind":"person","name":"MATEO ALAN","position":1,"cik":"0001595244","reported_name":"MATEO ALAN","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-02-25T22:22:04.000Z","date":"2025-02-21","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":11.1393,"value":445572.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $11.04 to $11.2751. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate sale price."}],"balance_after":61691,"source":{"system":"sec-edgar","filing":"0001610717-25-000034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595244/000161071725000034/form4.xml","form_type":"4"}},{"id":1322531,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-24T01:29:36.000Z","date":"2024-12-23","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, originally for 300,000 shares, of which 232,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021."}],"balance_after":67463,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001610717-24-000554","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000554/form4.xml","form_type":"4"}},{"id":1322530,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-24T01:29:36.000Z","date":"2024-12-23","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":1.2,"value":14400.0,"ownership":{"direct":true},"balance_after":884574,"source":{"system":"sec-edgar","filing":"0001610717-24-000554","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000554/form4.xml","form_type":"4"}},{"id":1352304,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-25T21:53:14.000Z","date":"2024-11-22","kind":"sale","planned":false,"acquired":false,"shares":6693,"price":13.6878,"value":91612.4454,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":872574,"source":{"system":"sec-edgar","filing":"0001610717-24-000530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000530/form4.xml","form_type":"4"}},{"id":1352303,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-25T21:53:14.000Z","date":"2024-11-21","kind":"gift","planned":false,"acquired":false,"shares":1850,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":879267,"source":{"system":"sec-edgar","filing":"0001610717-24-000530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000530/form4.xml","form_type":"4"}},{"id":1352302,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2024-11-25T21:52:29.000Z","date":"2024-11-22","kind":"sale","planned":false,"acquired":false,"shares":5807,"price":13.6878,"value":79485.0546,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":339897,"source":{"system":"sec-edgar","filing":"0001610717-24-000529","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000529/form4.xml","form_type":"4"}},{"id":1361267,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-18T21:43:55.000Z","date":"2024-11-14","kind":"gift","planned":false,"acquired":false,"shares":1350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":881117,"source":{"system":"sec-edgar","filing":"0001610717-24-000524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000524/form4.xml","form_type":"4"}},{"id":1416220,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":22969,"kind":"person","name":"Teichmann Sarah A.","position":1,"cik":"0002030916","reported_name":"Teichmann Sarah A.","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-09-04T21:34:30.000Z","date":"2024-08-30","kind":"grant","planned":false,"acquired":true,"shares":19002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the RSUs shall vest on November 21, 2025 and 1/12th of the RSUs shall vest on each quarterly anniversary thereafter for the following two years, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":19002,"source":{"system":"sec-edgar","filing":"0001610717-24-000461","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030916/000161071724000461/form4.xml","form_type":"4"}},{"id":1422935,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":2173,"kind":"person","name":"Saxonov Serge","position":1,"cik":"0001786720","reported_name":"Saxonov Serge","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-26T21:05:19.000Z","date":"2024-08-22","kind":"sale","planned":false,"acquired":false,"shares":6749,"price":22.5297,"value":152052.9453,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":882467,"source":{"system":"sec-edgar","filing":"0001610717-24-000455","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000455/form4.xml","form_type":"4"}},{"id":1422934,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":19364,"kind":"person","name":"Hindson Benjamin J.","position":1,"cik":"0001786391","reported_name":"Hindson Benjamin J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2024-08-26T21:04:29.000Z","date":"2024-08-22","kind":"sale","planned":false,"acquired":false,"shares":4351,"price":22.5297,"value":98026.7247,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":345704,"source":{"system":"sec-edgar","filing":"0001610717-24-000454","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000454/form4.xml","form_type":"4"}},{"id":1422932,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"other":true,"other_text":"Former Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-26T21:03:29.000Z","date":"2024-08-22","kind":"sale","planned":false,"acquired":false,"shares":2961,"price":22.5297,"value":66710.4417,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":143242,"source":{"system":"sec-edgar","filing":"0001610717-24-000453","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000453/form4.xml","form_type":"4"}}],"next_cursor":"2024-08-26T21:03:29.000000Z,1422932"}